Loading clinical trials...
Loading clinical trials...
Phase II Multicenter 16-Week Randomized Double Blind Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults With Down Syndrome
Conditions
Interventions
Memantine
Placebo
Locations
2
United States
University Hospitals Case Medical Center
Cleveland, Ohio, United States
Sociedade Beneficente Israelita Brasileira Albert Einstein
São Paulo, São Paulo, Brazil
Start Date
October 1, 2014
Primary Completion Date
July 22, 2020
Completion Date
July 22, 2020
Last Updated
June 27, 2023
NCT06019182
NCT04726241
NCT07234695
NCT07059858
NCT07248267
NCT07244133
Lead Sponsor
University Hospitals Cleveland Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions